Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions
Andreas O Doesch,1,* Li Zhao,1,* Christian A Gleissner,1 Mohammadreza Akhavanpoor,1 David Rohde,1 Deniz Okuyucu,1 Maani Hakimi,2 Thomas J Dengler,3 Hugo A Katus,1 Christian Erbel1 1Department of Cardiology, 2Department of Vascular Surgery, University of Heidelberg, Germany; 3Department of Cardiolog...
Main Authors: | Doesch AO, Zhao L, Gleissner CA, Akhavanpoor M, Rohde D, Okuyucu D, Hakimi M, Dengler TJ, Katus HA, Erbel C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-05-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/inhibition-of-b7-1-cd80-by-rhudexreg-reduces-lipopolysaccharide-mediat-peer-reviewed-article-DDDT |
Similar Items
-
CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions
by: Akhavanpoor M, et al.
Published: (2014-11-01) -
Effects of vildagliptin (Galvus®) therapy in patients with type 2 diabetes mellitus after heart transplantation
by: Gueler I, et al.
Published: (2013-04-01) -
Adventitial inflammation and its interaction with intimal atherosclerotic lesions
by: Mohammadreza eAkhavanpoor, et al.
Published: (2014-08-01) -
PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels
by: Erbel C, et al.
Published: (2011-08-01) -
Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study
by: Doesch AO, et al.
Published: (2013-11-01)